Abstract
During the first half of the century, there was virtually an exclusive reliance on animal testing as the primary model for drug discovery and development. New chemical entities were administered to rodents in the primary screen assay, and the appropriate responses were monitored for indications of therapeutic potential. Compounds meeting the appropriate potency and efficacy criteria were ‘promoted’ to more diverse and sophisticated animal models to characterize their pharmacological profile. The responses that were monitored included blood pressure (hypotensives), latency to respond to painful stimuli (analgesics), attenuation of seizure propensity (antiepileptics) and other responses that were intuitively and pharmacologically valid indicators of medicinal potential or toxicity. Some of these methods were semiautomated and quite sophisticated for their time, particularly for cardiovascular indications [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Freyburger, W.A., Weeks, J.R. and Ducharmem, D.W., Naunyn-Schmied. Arch. Pharmacol., 251 (1965) 39.
Goodman, F.R., In Williams, M. and Malick, J.B. (Eds.) Drug Discovery and Development, Humana Press, Clifton, NJ, U.S.A., 1987, pp. 97–109.
Ronai, A.Z., Berzetei, 1., Szekely, J.1., Graf, L. and Bajusz, S., Pharmacology, 18 (1979) 18.
Ward, S.J., Pierson, A.K. and Michne, W.F., Life Sci., 33 (Suppl. 1) (1983) 303.
Harris, A.L., Swamy, V.C. and Triggle, D.J., Can. J. Physiol. Pharmacol., 62 (1984) 146.
Webb, R.C. and Bohr, D.F., Am. Heart J., 102 (1981) 251.
Maxwell, R.A. and Eckhardt, S.B., Drug Discovery: A Casebook and Analysis, Humana Press, Clifton, NJ, U.S.A., 1990.
Shaw, I., J. Biomol. Screening, 1 (1996) 1.
France, D.S., Murdoch, M.K., Russel, M., Surve, N., Ma, X., Drelich, M., Duston, C., Hanson, A., Paterniti, J.R. and Weinstein, D.B., Lab. Robotics Autom., 5 (1993) 201.
Leatherbarrow, R.J., Trends Biochem. Sci., 15 (1990) 455.
Fleming, W.W., Westfall, D.P., De La Lande, I.S. and Jellett, L.B. J. Pharmacol. Exp. Ther., 181 (1972) 339.
Smith, G.S., The Process of New Drug Discovery and Development, CRC Press, Boca Raton, FL, U.S.A., 1992.
Reichman, M., Schneider, P.H., Anderson, S.N., Williamson, L.N. and Savage, M.A., Proc. Int. Symp. Lab. Autom. Robotics, 4 (1992) 466.
Janzen, B. and Domanico, P., J. Biomol. Screening, 2 (1996) 63.
Brandt, D.W., In Proceedings of the IBC Conference on High Throughput Screening, 1996, in press.
Quillan, J.M., Jayawickreme, C.K. and Lerner, M.R., Proc. Natl. Acad. Sci. USA, 92 (1995) 2894.
Devlin, J.J., Liang, A., Trinh, L., Polokoff, M.A., Senator, D., Zheng, W, Kondracki, J., Kretchmer, P.J., Morsel., J., Lipson, S.E., Spann, R., Loughlin, J.A., Dunn, K.V. and Morrissey, M.M., Drug Dev. Res., 37 (1996) 80.
Ciccarelli, R.B., Winter, L.A., Lorenz, R., Harris, A.L., Crawford, A.C., Bailey, T.R., Singh, B., Hammarskjold, M.-L., Rekosh, D. and Hughes, J.V., Antiviral Chem. Chemother., 5 (1994) 169.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Reichman, M., Harris, A.L. (1997). Practical high throughput screening. In: Moos, W.H., Pavia, M.R., Kay, B.K., Ellington, A.D. (eds) Annual Reports in Combinatorial Chemistry and Molecular Diversity. Annual Reports in Combinatorial Chemistry and Molecular Diversity, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-0-306-46904-6_18
Download citation
DOI: https://doi.org/10.1007/978-0-306-46904-6_18
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-0738-1
Online ISBN: 978-0-306-46904-6
eBook Packages: Springer Book Archive